Pediatrix Medical Group, Inc. (MD)
NYSE: MD · Real-Time Price · USD
24.15
-0.22 (-0.90%)
Jun 16, 2026, 4:00 PM EDT - Market closed
Pediatrix Medical Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 174.22 | 165.39 | -99.07 | -60.41 | 66.34 | 130.96 |
Depreciation & Amortization | 22.61 | 21.83 | 32.23 | 36.17 | 35.64 | 32.15 |
Stock-Based Compensation | 19.07 | 18.05 | 11.87 | 12.32 | 16.13 | 18.97 |
Other Adjustments | 52.46 | 27.65 | 183.99 | 169.62 | 32.39 | -44.95 |
Change in Receivables | 17.96 | 30.56 | 10.29 | 26.28 | -5.54 | -72.73 |
Changes in Accounts Payable | 6.55 | 28.33 | 51.14 | -11.92 | 0.42 | 21.33 |
Changes in Income Taxes Payable | 7.5 | -1.21 | -5.04 | -21.68 | 18.23 | -2.29 |
Changes in Other Operating Activities | -7.53 | -15.85 | 31.84 | -4.31 | 19.33 | 30.32 |
Operating Cash Flow | 258.71 | 271.09 | 206.57 | 137.33 | 166.94 | 76.74 |
Operating Cash Flow Growth | 20.70% | 31.23% | 50.43% | -17.74% | 117.55% | -62.50% |
Capital Expenditures | -21.39 | -18.46 | -22.02 | -33.33 | -29.71 | -32.25 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 24.73 |
Purchases of Investments | -29.1 | -29.85 | -64.55 | -31.89 | -17.35 | -15.05 |
Proceeds from Sale of Investments | 27.12 | 26.67 | 52.49 | 22.91 | 16.89 | 16.5 |
Payments for Business Acquisitions | -30.2 | -23.2 | -8.17 | -6.67 | -28.17 | -29.93 |
Proceeds from Business Divestments | - | 30 | - | - | - | - |
Other Investing Activities | 0.75 | -3.47 | 6.84 | 0.81 | 1.38 | -19.42 |
Investing Cash Flow | -22.81 | -18.3 | -35.41 | -48.18 | -56.95 | -53.07 |
Short-Term Debt Issued | - | - | 235.5 | 470 | 830 | - |
Short-Term Debt Repaid | - | - | -235.5 | -474 | -826 | - |
Net Short-Term Debt Issued (Repaid) | - | - | 0 | -4 | 4 | - |
Long-Term Debt Issued | - | - | - | - | 650 | - |
Long-Term Debt Repaid | -20.31 | -18.75 | -12.5 | -12.5 | -1,056 | -759.85 |
Net Long-Term Debt Issued (Repaid) | -20.31 | -18.75 | -12.5 | -12.5 | -406.26 | -759.85 |
Issuance of Common Stock | 3.07 | 3.18 | 3.64 | 4.91 | 5.4 | 6.85 |
Repurchase of Common Stock | -106.57 | -86.68 | -1.7 | -0.92 | -88.51 | -4.72 |
Net Common Stock Issued (Repurchased) | -103.5 | -83.5 | 1.94 | 3.99 | -83.12 | 2.13 |
Other Financing Activities | -2.1 | -5.25 | -3.92 | -13.21 | -2.18 | -2.4 |
Financing Cash Flow | -129.09 | -107.49 | -14.49 | -25.72 | -487.55 | -760.12 |
Net Cash Flow | 106.8 | 145.3 | 156.68 | 63.43 | -377.57 | -736.45 |
Free Cash Flow | 237.32 | 252.63 | 184.55 | 104 | 137.23 | 44.49 |
Free Cash Flow Growth | -6.06% | 36.89% | 77.46% | -24.22% | 208.46% | -74.70% |
FCF Margin | 12.29% | 13.20% | 9.17% | 5.21% | 6.96% | 2.33% |
Free Cash Flow Per Share | 2.80 | 2.96 | 2.21 | 1.27 | 1.63 | 0.52 |
Levered Free Cash Flow | 161.66 | 161.28 | -23.42 | -111.97 | -292.02 | -579.62 |
Unlevered Free Cash Flow | 175.21 | 174.2 | 20.98 | -25.92 | 176.68 | 231.07 |